J&J’s experimental antiviral drug exhibits promise in opposition to COVID-19 and rising coronaviruses
Johnson & Johnson’s pharmaceutical arm, Janssen, has shared early preclinical findings on its new antiviral drug, JNJ-9676, which exhibits promise ...
